Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Dec. 11, 2020, 5:06 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock rises Friday, outperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP advanced 1.52% to $1.34 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.16% to 30,046.37 and the NASDAQ Composite Index COMP falling 0.23% to 12,377.87. The stock's rise snapped a two-day losing streak. Corbus Pharmaceuticals Holdings Inc. closed $8.44 short of its 52-week high ($9.78), which the company reached on August 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Fate Therapeutics Inc. FATE fell 2.18% to $94.74, Vanda Pharmaceuticals Inc. VNDA fell 4.91% to $12.78, and Viking Therapeutics Inc. VKTX rose 2.61% to $6.29. Trading volume (5.0 M) eclipsed its 50-day average volume of 4.6 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.